(Q46417077)

22 December 2017

title

Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians (English)

1 reference

22 December 2017

author name string

Z Lu

1

1 reference

22 December 2017

B Dong

2

1 reference

22 December 2017

H Wu

3

1 reference

22 December 2017

T Chen

4

1 reference

22 December 2017

Y Zhang

5

1 reference

22 December 2017

J Wu

6

1 reference

22 December 2017

H Xiao

7

1 reference

22 December 2017

publication date

21 August 2008

1 reference

22 December 2017

Journal of Human Hypertension

published in

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

113-121

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/jhh.2008.104

exact match

0 references

cites work

Predictors of an increased risk of future hypertension in Utah. A screening analysis

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

ON CHRONIC BRIGHT'S DISEASE, AND ITS ESSENTIAL SYMPTOMS

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricaemia related to treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hypertension and hyperuricaemia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricemia in primary and renal hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

The incidence of hypertension and associated factors: The Israel ischemic heart disease study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricemia and incidence of hypertension among men without metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricemia in childhood primary hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Plasma uric acid level and risk for incident hypertension among men.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

A colorimetric method using uricase and peroxidase for the determination of uric acid

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum uric acid is a determinant of metabolic syndrome in a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

A role for uric acid in the progression of renal disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

A causal role for uric acid in fructose-induced metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid and inflammatory markers

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hormonal and cytokine effects of uric acid

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Multiple biomarkers and the risk of incident hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Predictors of mortality in very old subjects aged 80 years or over

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Controversies in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Serum urate determines antioxidant capacity in middle-aged men - a controlled, randomized diet and exercise intervention study.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Metabolic age modelling: the lesson from centenarians

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2008.104

7 January 2021

Identifiers

DOI

10.1038/JHH.2008.104

1 reference

22 December 2017

1 reference

22 December 2017